Evaluation of Respiratory Function During Self-induced Cognitive Trance (SPIROTRANSE)

C

Centre Hospitalier Metropole Savoie

Status

Completed

Conditions

Respiratory Function

Treatments

Diagnostic Test: spirometry

Study type

Interventional

Funder types

Other

Identifiers

NCT06121960
CHMS22009

Details and patient eligibility

About

The goal of this Prospective, monocentric, non-randomized, open-label study aimed at evaluating the variation of FEV1 during a state of self-induced cognitive trance participant population: Person with expertise in the practice of TCAI can be inclued. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry) The main question: Study the significant variation of FEV1 before, during, or after the state of self-induced cognitive trance

Full description

Primary objective : Study the significant variation of FEV1 before, during, or after the state of self-induced cognitive trance judgment criteria: Significant variations in: PEF PEF25 PEF50 PEF75 FVC Inspiratory capacity, SpO2 Respiratory rate before, during, or after the self-induced cognitive trance state Evolution of the feeling of self-efficacy, assessed by questionnaire

Enrollment

9 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Person over 18 years old
  • Person with expertise in the practice of TCAI. (at least 6 months, in order to be able to control the depth of the trance and to have a motor control allowing the realization of a spirometry)
  • Person affiliated with social security or beneficiary of such a scheme.
  • Person having given, in writing, their free and informed consent to participate in the study

Exclusion criteria

  • Person deprived of liberty by judicial or administrative decision, person subject to a measure of legal protection.
  • Exclusion period for other studies
  • Person likely, according to the investigator's assessment, not to be cooperative or respectful of the obligations inherent in participation in the study
  • Person with a psychiatric, neurological or cardiovascular disease.
  • Person with a chronic respiratory disease, for example: asthma, COPD, interstitial lung disease, bronchial dilation, cystic fibrosis,
  • Person with a history of exercise-induced bronchospasm.
  • Person taking inhaled treatments (corticotherapy, bronchodilators, anticholinergics)
  • Pregnant woman (declarative).

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

9 participants in 1 patient group

Interventionnal
Experimental group
Description:
Measure DEP, DEM25, DEM 50, DEM 75, FVC, Inspiratory capacity, SpO2, Respiratory rate before, during, or after the state of self-induced cognitive trance Evolution of the feeling of self-efficacy, assessed by questionnaire.
Treatment:
Diagnostic Test: spirometry

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems